...
首页> 外文期刊>Annals of diagnostic pathology >Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer.
【24h】

Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer.

机译:Cdx2,细胞角蛋白20,甲状腺转录因子1和前列腺特异抗原在前列腺癌的亚型中的表达。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

There are some unusual histologic variants of prostate carcinoma, including mucinous, signet-ring cells, and ductal carcinomas that can metastasize in a problematic way and simulate lung, colorectal, or bladder primaries. Currently, antibodies that are organ-specific have been used in the routine surgical pathology practice. Our aim is to study the profile of expression of Cdx2, thyroid transcription factor 1 (TTF1), and cytokeratin 20 (CK20) in prostate cancer with unusual histologic finding. Twenty-nine prostate adenocarcinomas with unusual histologic findings were submitted to immunohistochemistry with prostate-specific antigen (PSA), CK20, Cdx2, and TTF1 antibodies. There were 7 mucinous, 5 ductal, 2 signet-ring cells, and 15 usual acinar adenocarcinomas with focal mucinous differentiation. To compare the results with usual acinar adenocarcinomas, we studied 10 primary and their respective lymph node metastases in a tissue microarray, 2 unusual metastatic adenocarcinomas, and 6 usual acinar high-grade carcinomas. For tumors with special histologic finding, Cdx2 was expressed by 9 (31.0%) mucinous, signet-cell, or with focal mucinous differentiation. Thyroid transcription factor 1 was moderately positive in mucinous differentiation areas of 2 (6.9%) adenocarcinomas. Cytokeratin 20 was expressed by 9 (31.0%) tumors, among them, 3 ductal adenocarcinomas. Prostate-specific antigen was positive in 28 (96.6%) cases and negative in 1 ductal adenocarcinoma. There was only 1 worrisome ductal adenocarcinoma that was strongly CK20 positive and PSA negative. Almost one third of mucinous prostate carcinomas express Cdx2. Cytokeratin 20 can be positive also in one third of prostate carcinomas, especially the ductal type. Pathologist should be alert when evaluating immunohistochemical profiles of unusual histologic findings of prostate cancer, mostly in distant sites.
机译:前列腺癌有一些不寻常的组织学变异,包括黏液性,印戒细胞和导管癌,它们可以以有问题的方式转移并模拟肺,结直肠或膀胱原发性癌。目前,器官特异性抗体已用于常规外科病理学实践中。我们的目标是研究具有异常组织学发现的前列腺癌中Cdx2,甲状腺转录因子1(TTF1)和细胞角蛋白20(CK20)的表达情况。将具有异常组织学发现的29例前列腺腺癌与前列腺特异性抗原(PSA),CK20,Cdx2和TTF1抗体一起进行了免疫组织化学分析。有7个粘液性,5个导管性,2个印戒细胞和15个常见的腺泡腺癌,具有局灶性粘液性分化。为了将结果与常见的腺泡腺癌进行比较,我们在组织芯片中研究了10个原发性淋巴结转移及其各自的淋巴结转移,2个不寻常的转移性腺癌和6个常见的腺泡高级别癌。对于具有特殊组织学发现的肿瘤,Cdx2由9个(31.0%)粘液,印记细胞或局灶性粘液分化表达。甲状腺转录因子1在2个腺癌的黏液分化区域(6.9%)中度呈阳性。细胞角蛋白20在9例(31.0%)肿瘤中表达,其中3例在导管腺癌中表达。前列腺特异性抗原阳性28例(96.6%),阴性1例导管腺癌。仅有1例令人担忧的导管腺癌CK20阳性且PSA阴性。黏液性前列腺癌中近三分之一表达Cdx2。细胞角蛋白20在三分之一的前列腺癌(尤其是导管癌)中也可以呈阳性。在评估前列腺癌异常组织学发现(主要是在远处)的免疫组织化学特征时,病理学家应保持警惕。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号